PolyPeptide Group AG
SIX:PPGN
PolyPeptide Group AG
SIX:PPGN
Price:
24.75
CHF
-0.6%
Market Closed
Market Cap:
CHf820m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PolyPeptide Group AG
SIX:PPGN
|
CH |
|
James River Group Holdings Ltd
NASDAQ:JRVR
|
BM |
|
S
|
Stelrad Group PLC
LSE:SRAD
|
UK |
|
Shandong Weifang Rainbow Chemical Co Ltd
SZSE:301035
|
CN |
|
Ruida Futures Co Ltd
SZSE:002961
|
CN |
|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
US |
|
Ubisoft Entertainment SA
PAR:UBI
|
FR |
|
I
|
Indigo Exploration Inc
XTSX:IXI
|
CA |
|
Aces Electronics Co Ltd
TWSE:3605
|
TW |
|
Capstone Copper Corp
TSX:CS
|
CA |
Cash Flow Statement
Cash Flow Statement
PolyPeptide Group AG
PolyPeptide Group AG
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
47
|
33
|
8
|
(37)
|
(51)
|
(29)
|
(20)
|
(35)
|
(21)
|
|
| Depreciation & Amortization |
21
|
23
|
26
|
30
|
30
|
31
|
33
|
35
|
38
|
|
| Stock-Based Compensation |
4
|
5
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Non-Cash Items |
23
|
16
|
7
|
1
|
17
|
16
|
14
|
27
|
33
|
|
| Cash Taxes Paid |
11
|
13
|
8
|
3
|
1
|
(3)
|
2
|
1
|
4
|
|
| Cash Interest Paid |
2
|
3
|
2
|
3
|
5
|
7
|
9
|
8
|
9
|
|
| Change in Working Capital |
(33)
|
(63)
|
(35)
|
(29)
|
41
|
67
|
63
|
110
|
28
|
|
| Cash from Operating Activities |
57
N/A
|
9
-85%
|
5
-37%
|
(35)
N/A
|
36
N/A
|
85
+134%
|
89
+5%
|
139
+55%
|
78
-44%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(78)
|
(84)
|
(79)
|
(69)
|
(57)
|
(55)
|
(87)
|
(106)
|
(109)
|
|
| Other Items |
(3)
|
(3)
|
0
|
1
|
(3)
|
(6)
|
(4)
|
(3)
|
(3)
|
|
| Cash from Investing Activities |
(81)
N/A
|
(87)
-7%
|
(78)
+10%
|
(68)
+13%
|
(60)
+13%
|
(61)
-2%
|
(91)
-50%
|
(110)
-20%
|
(112)
-2%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
177
|
(12)
|
(14)
|
(2)
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Issuance of Debt |
(41)
|
(35)
|
(3)
|
52
|
85
|
19
|
(25)
|
5
|
34
|
|
| Cash Paid for Dividends |
0
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
|
| Cash from Financing Activities |
131
N/A
|
(56)
N/A
|
(27)
+52%
|
50
N/A
|
85
+69%
|
19
-78%
|
(25)
N/A
|
(6)
+77%
|
34
N/A
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
12
|
14
|
1
|
(4)
|
(3)
|
(4)
|
(0)
|
5
|
7
|
|
| Net Change in Cash |
119
N/A
|
(121)
N/A
|
(99)
+18%
|
(57)
+42%
|
58
N/A
|
39
-32%
|
(27)
N/A
|
28
N/A
|
6
-78%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(20)
N/A
|
(75)
-269%
|
(73)
+2%
|
(104)
-42%
|
(20)
+81%
|
30
N/A
|
2
-92%
|
32
+1 225%
|
(31)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
